{"title":"sars-cov-2感染过程中一些临床实验室参数的特征性变化","authors":"P. Teneva, Ivelina Dobreva","doi":"10.5272/jimab.2023293.5026","DOIUrl":null,"url":null,"abstract":"Global coronavirus disease 2019 (COVID-19) has posed major challenges to clinical laboratories, from initial diagnosis to patient monitoring and treatment. Some routine laboratory markers reveal a range of changes in patients with COVID-19. Among the most frequently observed are: increased levels of C-Reactive Protein (CRP), Lactate dehydrogenase (LDH), D-Dimer neutrophilia with lymphopenia and decreased platelet count. The aim of our study is to present the changes in the values of CRP, LDH, D-Dimer, number of Thrombocytes (PLT), Lymphocytes (Ly) and Neutrophils (Neu) during hospitalization and at the discharge of patients with Sars-Cov-2. Materials and methods: The object of the study are clinical laboratory results of 106 patients who underwent hospital treatment for Covid -19 in the \"St. Ivan Rilski\" St. Zagora, divided into two groups. The first group (Group I) is in the period November-December 2020, the second group (Group II) patients were hospitalized in April 2021. The values of CRP, LDH, D-Dimer, number of platelets, Ly, Neu from the day of the patient's admission to the hospital and from his discharge were examined. Results and discussion: In 100% of the examined patients in the first group CRP with values at the time of admission to the hospital (TAH) 88.70 ± 63.132 mg/L. LDH was increased in three of the groups in more than 90% of the patients, with the highest values of the enzyme being recorded in Group II at the end of hospitalization, 802.33 U/L (± 557.836). In the studied groups, we found significantly more patients with elevated values in both groups at discharge (Group I 49.12% and Group II 46.94%). The highest number of patients with thrombocytopenia was observed in Group II at the time of admission to the hospital, 26.53% (n=13). Conclusion: Quantification of these and other laboratory parameters could significantly aid the detection of at-risk patients and reveal disease severity. They represent objective and standardized criteria guiding therapy.","PeriodicalId":339756,"journal":{"name":"Journal of IMAB - Annual Proceeding (Scientific Papers)","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CHARACTERISTIC CHANGES IN SOME CLINICAL LABORATORY PARAMETERS OF THE SARS-COV-2 INFECTION IN THE COURSE OF THE DISEASE\",\"authors\":\"P. Teneva, Ivelina Dobreva\",\"doi\":\"10.5272/jimab.2023293.5026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Global coronavirus disease 2019 (COVID-19) has posed major challenges to clinical laboratories, from initial diagnosis to patient monitoring and treatment. Some routine laboratory markers reveal a range of changes in patients with COVID-19. Among the most frequently observed are: increased levels of C-Reactive Protein (CRP), Lactate dehydrogenase (LDH), D-Dimer neutrophilia with lymphopenia and decreased platelet count. The aim of our study is to present the changes in the values of CRP, LDH, D-Dimer, number of Thrombocytes (PLT), Lymphocytes (Ly) and Neutrophils (Neu) during hospitalization and at the discharge of patients with Sars-Cov-2. Materials and methods: The object of the study are clinical laboratory results of 106 patients who underwent hospital treatment for Covid -19 in the \\\"St. Ivan Rilski\\\" St. Zagora, divided into two groups. The first group (Group I) is in the period November-December 2020, the second group (Group II) patients were hospitalized in April 2021. The values of CRP, LDH, D-Dimer, number of platelets, Ly, Neu from the day of the patient's admission to the hospital and from his discharge were examined. Results and discussion: In 100% of the examined patients in the first group CRP with values at the time of admission to the hospital (TAH) 88.70 ± 63.132 mg/L. LDH was increased in three of the groups in more than 90% of the patients, with the highest values of the enzyme being recorded in Group II at the end of hospitalization, 802.33 U/L (± 557.836). In the studied groups, we found significantly more patients with elevated values in both groups at discharge (Group I 49.12% and Group II 46.94%). The highest number of patients with thrombocytopenia was observed in Group II at the time of admission to the hospital, 26.53% (n=13). Conclusion: Quantification of these and other laboratory parameters could significantly aid the detection of at-risk patients and reveal disease severity. They represent objective and standardized criteria guiding therapy.\",\"PeriodicalId\":339756,\"journal\":{\"name\":\"Journal of IMAB - Annual Proceeding (Scientific Papers)\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of IMAB - Annual Proceeding (Scientific Papers)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5272/jimab.2023293.5026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of IMAB - Annual Proceeding (Scientific Papers)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5272/jimab.2023293.5026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
2019年全球冠状病毒病(COVID-19)给临床实验室带来了重大挑战,从初步诊断到患者监测和治疗。一些常规实验室标志物揭示了COVID-19患者的一系列变化。其中最常见的是:c反应蛋白(CRP)水平升高,乳酸脱氢酶(LDH), d -二聚体嗜中性粒细胞伴淋巴细胞减少和血小板计数减少。我们的研究目的是了解Sars-Cov-2患者住院期间和出院时CRP、LDH、d -二聚体、血小板(PLT)、淋巴细胞(Ly)和中性粒细胞(Neu)数量的变化。材料与方法:研究对象为在“圣伊万·里尔斯基”圣扎戈拉医院接受新冠肺炎住院治疗的106例患者的临床实验室结果,分为两组。第一组(第一组)患者于2020年11月至12月住院,第二组(第二组)患者于2021年4月住院。检测患者入院当日及出院当日CRP、LDH、d -二聚体、血小板数、Ly、Neu值。结果与讨论:在100%被检查的第一组患者中,CRP与入院时的值(TAH)为88.70±63.132 mg/L。3组患者LDH升高,均超过90%,其中II组患者在住院结束时LDH最高,为802.33 U/L(±557.836)。在研究组中,我们发现两组出院时升高的患者明显更多(I组49.12%,II组46.94%)。第二组患者入院时出现血小板减少的人数最多,为26.53% (n=13)。结论:这些及其他实验室参数的定量分析有助于发现高危患者并揭示疾病严重程度。它们代表了指导治疗的客观和标准化的标准。
CHARACTERISTIC CHANGES IN SOME CLINICAL LABORATORY PARAMETERS OF THE SARS-COV-2 INFECTION IN THE COURSE OF THE DISEASE
Global coronavirus disease 2019 (COVID-19) has posed major challenges to clinical laboratories, from initial diagnosis to patient monitoring and treatment. Some routine laboratory markers reveal a range of changes in patients with COVID-19. Among the most frequently observed are: increased levels of C-Reactive Protein (CRP), Lactate dehydrogenase (LDH), D-Dimer neutrophilia with lymphopenia and decreased platelet count. The aim of our study is to present the changes in the values of CRP, LDH, D-Dimer, number of Thrombocytes (PLT), Lymphocytes (Ly) and Neutrophils (Neu) during hospitalization and at the discharge of patients with Sars-Cov-2. Materials and methods: The object of the study are clinical laboratory results of 106 patients who underwent hospital treatment for Covid -19 in the "St. Ivan Rilski" St. Zagora, divided into two groups. The first group (Group I) is in the period November-December 2020, the second group (Group II) patients were hospitalized in April 2021. The values of CRP, LDH, D-Dimer, number of platelets, Ly, Neu from the day of the patient's admission to the hospital and from his discharge were examined. Results and discussion: In 100% of the examined patients in the first group CRP with values at the time of admission to the hospital (TAH) 88.70 ± 63.132 mg/L. LDH was increased in three of the groups in more than 90% of the patients, with the highest values of the enzyme being recorded in Group II at the end of hospitalization, 802.33 U/L (± 557.836). In the studied groups, we found significantly more patients with elevated values in both groups at discharge (Group I 49.12% and Group II 46.94%). The highest number of patients with thrombocytopenia was observed in Group II at the time of admission to the hospital, 26.53% (n=13). Conclusion: Quantification of these and other laboratory parameters could significantly aid the detection of at-risk patients and reveal disease severity. They represent objective and standardized criteria guiding therapy.